+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Bioabsorbable Stents (BAS) - Medical Devices Pipeline Assessment, 2019

  • ID: 4898194
  • Report
  • December 2019
  • Region: Global
  • 119 Pages
  • GlobalData
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

FEATURED COMPANIES

  • Abbott Vascular Inc
  • Biotronik AG
  • Cordis Corp
  • Minvasys SAS
  • OrbusNeich
  • Tepha Inc
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Bioabsorbable Stents (BAS) - Medical Devices Pipeline Assessment, 2019

Summary

The Medical Devices sector report, “Bioabsorbable Stents (BAS) - Medical Devices Pipeline Assessment, 2019“ provides an overview of Bioabsorbable Stents (BAS) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Bioabsorbable Stents (BAS) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by the team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Bioabsorbable Stents (BAS) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Bioabsorbable Stents (BAS) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Bioabsorbable Stents (BAS) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Vascular Inc
  • Biotronik AG
  • Cordis Corp
  • Minvasys SAS
  • OrbusNeich
  • Tepha Inc

1 Introduction
1.1 Bioabsorbable Stents (BAS) Overview
2 Products under Development
2.1 Bioabsorbable Stents (BAS) - Pipeline Products by Stage of Development
2.2 Bioabsorbable Stents (BAS) - Pipeline Products by Territory
2.3 Bioabsorbable Stents (BAS) - Pipeline Products by Regulatory Path
2.4 Bioabsorbable Stents (BAS) - Pipeline Products by Estimated Approval Date
2.5 Bioabsorbable Stents (BAS) - Ongoing Clinical Trials
3 Bioabsorbable Stents (BAS) - Pipeline Products under Development by Companies
3.1 Bioabsorbable Stents (BAS) Companies - Pipeline Products by Stage of Development
3.2 Bioabsorbable Stents (BAS) - Pipeline Products by Stage of Development
4 Bioabsorbable Stents (BAS) Companies and Product Overview
4.1 Abbott Vascular Inc Company Overview
4.1.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
4.2 Amaranth Medical Inc Company Overview
4.2.1 Amaranth Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
4.3 Arterius Ltd Company Overview
4.3.1 Arterius Ltd Pipeline Products & Ongoing Clinical Trials Overview
4.4 Biosensors International Group Ltd Company Overview
4.4.1 Biosensors International Group Ltd Pipeline Products & Ongoing Clinical Trials Overview
4.5 Biosten, LLC Company Overview
4.5.1 Biosten, LLC Pipeline Products & Ongoing Clinical Trials Overview
4.6 Biotronik AG Company Overview
4.6.1 Biotronik AG Pipeline Products & Ongoing Clinical Trials Overview
4.7 Biotronik SE & Co KG Company Overview
4.7.1 Biotronik SE & Co KG Pipeline Products & Ongoing Clinical Trials Overview
4.8 Boston Scientific Corp Company Overview
4.8.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
4.9 Cardionovum GmbH Company Overview
4.9.1 Cardionovum GmbH Pipeline Products & Ongoing Clinical Trials Overview
4.10 Cordis Corp Company Overview
4.10.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview
4.11 HangZhou HuaAn Biotechnology Co., Ltd. Company Overview
4.11.1 HangZhou HuaAn Biotechnology Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
4.12 Icon Interventional Systems, Inc. Company Overview
4.12.1 Icon Interventional Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
4.13 Japan Stent Technology Co., Ltd. Company Overview
4.13.1 Japan Stent Technology Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
4.14 Kyoto Medical Planning Co Ltd Company Overview
4.14.1 Kyoto Medical Planning Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
4.15 Lifetech Scientific (Shenzhen) Co Ltd Company Overview
4.15.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
4.16 Manli Cardiology Ltd Company Overview
4.16.1 Manli Cardiology Ltd Pipeline Products & Ongoing Clinical Trials Overview
4.17 Micell Technologies Inc Company Overview
4.17.1 Micell Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
4.18 Michigan Technological University Company Overview
4.18.1 Michigan Technological University Pipeline Products & Ongoing Clinical Trials Overview
4.19 MicroPort Scientific Corp Company Overview
4.19.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
4.20 Minvasys SAS Company Overview
4.20.1 Minvasys SAS Pipeline Products & Ongoing Clinical Trials Overview
4.21 MIV Therapeutics Inc Company Overview
4.21.1 MIV Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
4.22 NanoCoeur, Inc. Company Overview
4.22.1 NanoCoeur, Inc. Pipeline Products & Ongoing Clinical Trials Overview
4.23 North Carolina State University Company Overview
4.23.1 North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview
4.24 Northwestern University Company Overview
4.24.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
4.25 OrbusNeich Company Overview
4.25.1 OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview
4.26 Pediastent LLC Company Overview
4.26.1 Pediastent LLC Pipeline Products & Ongoing Clinical Trials Overview
4.27 QualiMed Innovative Medizinprodukte GmbH Company Overview
4.27.1 QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview
4.28 REVA Medical Inc Company Overview
4.28.1 REVA Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
4.29 S3V Vascular Technologies Company Overview
4.29.1 S3V Vascular Technologies Pipeline Products & Ongoing Clinical Trials Overview
4.30 Tepha Inc Company Overview
4.30.1 Tepha Inc Pipeline Products & Ongoing Clinical Trials Overview
4.31 University of Alabama at Birmingham Company Overview
4.31.1 University of Alabama at Birmingham Pipeline Products & Ongoing Clinical Trials Overview
4.32 University of Florida Company Overview
4.32.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview
4.33 University of Strathclyde Company Overview
4.33.1 University of Strathclyde Pipeline Products & Ongoing Clinical Trials Overview
4.34 VasoTech Inc. Company Overview
4.34.1 VasoTech Inc. Pipeline Products & Ongoing Clinical Trials Overview
4.35 Xenogenics Corporation Company Overview
4.35.1 Xenogenics Corporation Pipeline Products & Ongoing Clinical Trials Overview
5 Bioabsorbable Stents (BAS)- Recent Developments
5.1 Nov 06, 2019: Final five unpublished late-breaking clinical trial results announced at VIVA19
5.2 Oct 23, 2019: Boston Scientific announces results for third quarter 2019
5.3 Sep 20, 2019: Terumo to increase production capacity for alliance business
5.4 Aug 29, 2019: MicroPort announces interim results for the six months ended June 30, 2019
5.5 Aug 28, 2019: Boston Scientific Celebrates 15th Anniversary in Costa Rica
6 Appendix
6.1 Methodology
6.2 About the Author
6.3 Contact Us
6.4 Disclaimer
List of Tables
Table 1: Bioabsorbable Stents (BAS) - Pipeline Products by Stage of Development
Table 2: Bioabsorbable Stents (BAS) - Pipeline Products by Territory
Table 3: Bioabsorbable Stents (BAS) - Pipeline Products by Regulatory Path
Table 4: Bioabsorbable Stents (BAS) - Pipeline Products by Estimated Approval Date
Table 5: Bioabsorbable Stents (BAS) - Ongoing Clinical Trials
Table 6: Bioabsorbable Stents (BAS) Companies - Pipeline Products by Stage of Development
Table 7: Bioabsorbable Stents (BAS) - Pipeline Products by Stage of Development
Table 8: Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Second Generation Bioresorbable Vascular Scaffold - Product Status
Table 10: Second Generation Bioresorbable Vascular Scaffold - Product Description
Table 11: Amaranth Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 12: 80-micron MAGNITUDE Bioresorbable Scaffold - Product Status
Table 13: 80-micron MAGNITUDE Bioresorbable Scaffold - Product Description
Table 14: APTITUDE Sirolimus-Eluting Bioresorbable Scaffold - Product Status
Table 15: APTITUDE Sirolimus-Eluting Bioresorbable Scaffold - Product Description
Table 16: DEFIANCE Scaffold - Product Status
Table 17: DEFIANCE Scaffold - Product Description
Table 18: FORTITUDE Scaffold - Product Status
Table 19: FORTITUDE Scaffold - Product Description
Table 20: MAGNITUDE Sirolimus-Eluting Bioresorbable Scaffold - Product Status
Table 21: MAGNITUDE Sirolimus-Eluting Bioresorbable Scaffold - Product Description
Table 22: Second Generation FORTITUDE Scaffold - Product Status
Table 23: Second Generation FORTITUDE Scaffold - Product Description
Table 24: Amaranth Medical Inc - Ongoing Clinical Trials Overview
Table 25: FORTITUDE Scaffold - Amaranth Endovascular Study of a Drug-eluting Bioresorbable Coronary Scaffold
Table 26: FORTITUDE Scaffold - Restoring Endoluminal Narrowing Using Bioresorbable Scaffolds - European Trial
Table 27: APTITUDE Sirolimus-Eluting Bioresorbable Scaffold - Restoring Endoluminal Narrowing Using Bioresorbable Scaffolds - Extended Trial II
Table 28: MAGNITUDE Sirolimus-Eluting Bioresorbable Scaffold - Restoring Endoluminal Narrowing Using Bioresorbable Scaffolds - Extended Trial III
Table 29: Arterius Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 30: Arteriosorb Absorbable Drug-Eluting Scaffold - Product Status
Table 31: Arteriosorb Absorbable Drug-Eluting Scaffold - Product Description
Table 32: Biosensors International Group Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Sparrow Drug Eluting Stent System - Product Status
Table 34: Sparrow Drug Eluting Stent System - Product Description
Table 35: Biosten, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 36: Biodegradable Endovascular Implant - Product Status
Table 37: Biodegradable Endovascular Implant - Product Description
Table 38: Biotronik AG Pipeline Products & Ongoing Clinical Trials Overview
Table 39: Magmaris Bioresorbable Magnesium Scaffold - Product Status
Table 40: Magmaris Bioresorbable Magnesium Scaffold - Product Description
Table 41: Magmaris Bioresorbable Magnesium Scaffold - 3rd Generation - Product Status
Table 42: Magmaris Bioresorbable Magnesium Scaffold - 3rd Generation - Product Description
Table 43: Biotronik AG - Ongoing Clinical Trials Overview
Table 44: Magmaris Bioresorbable Magnesium Scaffold - A Sirolimus Eluting Bioresorbable Magnesium Stent for Treatment of Coronary Bifurcation Lesions: The BIFSORB Pilot Study II
Table 45: Magmaris Bioresorbable Magnesium Scaffold - BIOTRONIK - Safety and Clinical Performance of the Drug Eluting Absorbable Metal Scaffold (DREAMS 2nd Generation) in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries: BIOSOLVE-II
Table 46: Magmaris Bioresorbable Magnesium Scaffold - BIOTRONIKS - Acute Performance of a Drug Eluting Absorbable Metal Scaffold (DREAMS 2G) in Patients with de Novo Lesions in Native Coronary Arteries: BIOSOLVE-III
Table 47: Magmaris Bioresorbable Magnesium Scaffold - Biotroniks - Safety and Performance in de Novo Lesion of Native Coronary Arteries with Magmaris- Registry: BIOSOLVE-IV
Table 48: Magmaris Bioresorbable Magnesium Scaffold - BIOTRONIKS-Safety and Performance in de Novo Lesion of Native Coronary Arteries with Magmaris (BIOSOLVE)-IV Magmaris Swiss Satellite Registry
Table 49: Magmaris Bioresorbable Magnesium Scaffold - Coronary Artery Healing Process after Bioresorbable Scaffold in Patients with Non-ST-segment Elevation Myocardial Infarction (NSTEMI)
Table 50: Magmaris Bioresorbable Magnesium Scaffold - Magnesium-based Bioresorbable Scaffold and Vasomotor Function in Patients with Acute ST Segment Elevation Myocardial Infarction
Table 51: Magmaris Bioresorbable Magnesium Scaffold - Optical Coherence Guided Treatment of ST-segment Elevation Myocardial Infarction with the Drug-eluting Resorbable Magnesium Scaffold: The BEST- MAG Multicentre Study (Belgian ST-segment Elevation Myocardial Infarction Treatment with Resorbable Magnesium Scaffold)
Table 52: Magmaris Bioresorbable Magnesium Scaffold - Optical Coherence Tomography Evaluation of Bioabsorbable Vascular Scaffold Technique with Magmaris
Table 53: Magmaris Bioresorbable Magnesium Scaffold - Prospective Observational Registry of Patients with a Bioabsorbable Magnesium Stent Implant -MAGMARIS- in Usual Clinical Practice
Table 54: Magmaris Bioresorbable Magnesium Scaffold - Retrospective, Observational Register to Investigate the Procedural and Post Procedural Implantation of Bioabsorbable Magnesium Scaffolds MAGMARIS (MAGIC Registry)
Table 55: Magmaris Bioresorbable Magnesium Scaffold - Scaffold Implantation in Emilia-Romagna
Table 56: Magmaris Bioresorbable Magnesium Scaffold - 3rd Generation - BIOTRONIK - Safety and Clinical Performance of the - Sirolimus-Eluting Resorbable Coronary Magnesium Scaffold System (DREAMS 3G) in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries
Table 57: Biotronik SE & Co KG Pipeline Products & Ongoing Clinical Trials Overview
Table 58: AMS-2 - Product Status
Table 59: AMS-2 - Product Description
Table 60: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 61: Fully Resorbable Drug-Eluting Scaffold System - Product Status
Table 62: Fully Resorbable Drug-Eluting Scaffold System - Product Description
Table 63: SYNERGY DES 4.5/5.0 - Product Status
Table 64: SYNERGY DES 4.5/5.0 - Product Description
Table 65: Boston Scientific Corp - Ongoing Clinical Trials Overview
Table 66: SYNERGY DES 4.5/5.0 - A U.S. Post-approval Study of the SYNERGY 4.50/5.00 mm Everolimus-eluting Platinum Chromium Coronary Stent System (Evolve 4.5/5.0)
List of Figures
Figure 1: Bioabsorbable Stents (BAS) - Pipeline Products by Stage of Development
Figure 2: Bioabsorbable Stents (BAS) - Pipeline Products by Territory
Figure 3: Bioabsorbable Stents (BAS) - Pipeline Products by Regulatory Path
Figure 4: Bioabsorbable Stents (BAS) - Pipeline Products by Estimated Approval Date
Figure 5: Bioabsorbable Stents (BAS) - Ongoing Clinical Trials
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Abbott Vascular Inc
  • Amaranth Medical Inc
  • Arterius Ltd
  • Biosensors International Group Ltd
  • Biosten, LLC
  • Biotronik AG
  • Biotronik SE & Co KG
  • Boston Scientific Corp
  • Cardionovum GmbH
  • Cordis Corp
  • HangZhou HuaAn Biotechnology Co., Ltd.
  • Icon Interventional Systems, Inc.
  • Japan Stent Technology Co., Ltd.
  • Kyoto Medical Planning Co Ltd
  • Lifetech Scientific (Shenzhen) Co Ltd
  • Manli Cardiology Ltd
  • Micell Technologies Inc
  • Michigan Technological University
  • MicroPort Scientific Corp
  • Minvasys SAS
  • MIV Therapeutics Inc
  • NanoCoeur, Inc.
  • North Carolina State University
  • Northwestern University
  • OrbusNeich
  • Pediastent LLC
  • QualiMed Innovative Medizinprodukte GmbH
  • REVA Medical Inc
  • S3V Vascular Technologies
  • Tepha Inc
  • University of Alabama at Birmingham
  • University of Florida
  • University of Strathclyde
  • VasoTech Inc.
  • Xenogenics Corporation
Note: Product cover images may vary from those shown